Vitamin B12 supplementation as novel therapeutic strategy to improve cancer-associated outcomes
Vitamin B12 supplementation as novel therapeutic strategy to improve cancer-associated outcomes
批准号:
10509128
负责人:
Ana da silva Gomes
金额:
$16.85万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-10 至 2023-08-31
关键词:
AffectAgeAgingAwardCancer PatientCancer PrognosisDevelopmentDiagnosisDiseaseElderlyFundingImmune EvasionIndividualInterventionMalignant NeoplasmsMediatingMetabolicMethylmalonic AcidOutcomeParentsPersonsPhysiologicalProcessQuality of lifeResearchRisk FactorsSupplementationT-LymphocyteTherapeutic InterventionTumor-infiltrating immune cellsVitamin B 12Vitamin B 12 DeficiencyVitamin DeficiencyVulnerable Populationsanticancer researchcancer cellimprovednovel therapeutic interventiontherapeutic developmenttherapeutically effectivetumor progressiontumorigenic
中文摘要
项目总结
虽然癌症是一种老年人的疾病,但伴随着衰老过程的深刻变化
在肿瘤形成过程的研究或治疗方法的开发中很少考虑
治疗癌症的策略。因此,全面了解生物体是如何
需要随着年龄的增长而重新编程,以刺激更有效的发展
可改善癌症患者生活质量和预后的治疗策略和干预措施
平均年龄的患者。我们之前已经确认循环甲基丙二酸是一种
随着年龄的增长而积累的共生代谢产物,至少在一定程度上调节了
老年人的肿瘤进展速度加快。通过资助的研究
父母奖,我们发现甲基丙二酸发挥其促进攻击性的作用
通过直接对癌细胞重新编程以及间接通过抑制T细胞和
从而促进免疫逃避。甲基丙二酸在健康人群中的蓄积
个人主要归因于维生素B12缺乏,这在老年人中很常见
人民。在这一补充中,我们假设纠正旧宿主中的维生素B12将恢复
甲基丙二酸增加到生理水平,从而影响肿瘤的形成过程。
因此,在这项应用中,我们将在老年宿主中补充维生素B12,并评估1)维生素
在老年宿主中补充B12可以抑制癌症进展;2)如果维生素B12
补充剂可改善T细胞的渗透和功能。
英文摘要
PROJECT SUMMARY
While cancer is a disease of the old, the profound alterations that accompany the aging process
are rarely considered in the study of the tumorigenic process or in the development of therapeutic
strategies to treat cancer. Thus, a comprehensive understanding of how the organismal
reprogramming that occur with age is needed to spur the development of more effective
therapeutic strategies and interventions that can ameliorate quality of life and outcome of cancer
patients of average age. We have previously identified circulatory methylmalonic acid as an
oncometabolite whose accumulation occurs with age and mediates, at least in part, the
accelerated pace of tumor progression that occurs in old people. Through the research funded by
the parent award, we have discovered that methylmalonic acid exerts its pro-aggressive effects
by directly reprogramming cancer cells as well as indirectly by suppressing T cells and
consequently promoting immune evasion. Methylmalonic acid accumulation in otherwise healthy
individuals has been mostly attributed to vitamin B12 deficiency, a common occurrence in older
people. In this supplement, we hypothesize that correcting vitamin B12 in old hosts will restore
methylmalonic acid to physiological levels and consequently affect the tumorigenic process.
Therefore, in this application we will supplement vitamin B12 in old hosts and evaluate if 1) vitamin
B12 supplementation in old hosts suppresses cancer progression; and 2) if vitamin B12
supplementation improves T cell infiltration and function.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1002/1878-0261.13261
发表时间:
2022-09
期刊:
MOLECULAR ONCOLOGY
影响因子:
6.6
作者:
[Drapela, Stanislav, Ilter, Didem, Gomes, Ana P.]
通讯作者:
Gomes, Ana P.
Adaptations of breast cancer metastasis to the aging lung
-
批准号:10726328
-
项目类别:
-
资助金额:$21.06万
-
财政年份:2023
-
负责人:Ana da silva Gomes
-
依托单位:
AGING AS A SELECTIVE PRESSURE THAT DRIVES TUMOR PROGRESSION
-
批准号:10245907
-
项目类别:
-
资助金额:$148.23万
-
财政年份:2021
-
负责人:Ana da silva Gomes
-
依托单位:
Propionate metabolism as an essential metabolic adaptation for tumor progression
-
批准号:10261595
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2020
-
负责人:Ana da silva Gomes
-
依托单位:
Propionate metabolism as an essential metabolic adaptation for tumor progression
-
批准号:10457486
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2020
-
负责人:Ana da silva Gomes
-
依托单位:
Propionate metabolism as an essential metabolic adaptation for tumor progression
-
批准号:9370756
-
项目类别:
-
资助金额:$8.44万
-
财政年份:2017
-
负责人:Ana da silva Gomes
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: